Corteva (NYSE:CTVA) Issues FY 2025 Earnings Guidance

Key Points

• Corteva has updated its FY 2025 earnings guidance, projecting an EPS of 3.000-3.200 and revenue between $17.6 billion and $17.8 billion, aligning closely with consensus estimates.
• Wall Street analysts have generally rated Corteva positively, with thirteen analysts giving it a "Buy" rating and an average price target of $82.00.
• The company recently raised its dividend from $0.17 to $0.18 per quarter, indicating a commitment to returning value to shareholders.

Corteva (NYSE:CTVA - Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 3.000-3.200 for the period, compared to the consensus EPS estimate of 3.140. The company issued revenue guidance of $17.6 billion-$17.8 billion, compared to the consensus revenue estimate of $17.6 billion.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on CTVA shares. Zacks Research upgraded shares of Corteva to a "hold" rating in a research report on Friday, August 8th. Barclays upgraded Corteva from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $75.00 to $84.00 in a research note on Wednesday, August 13th. Oppenheimer set a $87.00 price target on Corteva and gave the company an "outperform" rating in a report on Tuesday, July 15th. BMO Capital Markets set a $86.00 price objective on shares of Corteva in a research report on Monday, September 15th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Corteva from $83.00 to $90.00 and gave the company a "buy" rating in a research report on Monday, September 15th. Thirteen research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $82.00.

Corteva Price Performance

Shares of CTVA stock opened at $67.63 on Wednesday. The firm has a market cap of $45.93 billion, a price-to-earnings ratio of 32.99, a P/E/G ratio of 1.55 and a beta of 0.78. The stock's fifty day simple moving average is $71.89 and its 200 day simple moving average is $68.88. Corteva has a one year low of $53.40 and a one year high of $77.41. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.68 and a quick ratio of 1.23.

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share for the quarter, beating analysts' consensus estimates of $1.89 by $0.31. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The company had revenue of $6.46 billion during the quarter, compared to analyst estimates of $6.26 billion. During the same period last year, the company posted $1.83 earnings per share. The firm's quarterly revenue was up 5.6% compared to the same quarter last year. On average, analysts expect that Corteva will post 2.96 earnings per share for the current fiscal year.

Corteva Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were paid a $0.18 dividend. This is a boost from Corteva's previous quarterly dividend of $0.17. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.1%. Corteva's dividend payout ratio (DPR) is currently 35.12%.

Insider Buying and Selling

In related news, EVP Robert D. King sold 37,280 shares of the firm's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the sale, the executive vice president directly owned 49,262 shares in the company, valued at $3,655,240.40. This trade represents a 43.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.15% of the company's stock.

Institutional Trading of Corteva

Hedge funds and other institutional investors have recently made changes to their positions in the business. Advisory Services Network LLC raised its holdings in Corteva by 197.8% during the second quarter. Advisory Services Network LLC now owns 28,801 shares of the company's stock worth $2,077,000 after acquiring an additional 19,129 shares in the last quarter. Geneos Wealth Management Inc. increased its position in shares of Corteva by 62.5% during the 2nd quarter. Geneos Wealth Management Inc. now owns 5,330 shares of the company's stock worth $397,000 after purchasing an additional 2,050 shares during the last quarter. Caxton Associates LLP acquired a new position in shares of Corteva during the 2nd quarter worth approximately $387,000. Tower Research Capital LLC TRC grew its stake in shares of Corteva by 78.5% in the second quarter. Tower Research Capital LLC TRC now owns 42,671 shares of the company's stock valued at $3,180,000 after buying an additional 18,769 shares in the last quarter. Finally, MUFG Securities EMEA plc bought a new position in shares of Corteva in the second quarter valued at $151,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.